Details for New Drug Application (NDA): 018584
✉ Email this page to a colleague
The generic ingredient in BECONASE is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.
Summary for 018584
Tradename: | BECONASE |
Applicant: | Glaxosmithkline |
Ingredient: | beclomethasone dipropionate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;NASAL | Strength | 0.042MG/INH | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018584
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BECONASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018584-001 | Approved Prior to Jan 1, 1982 | 4,364,923 | ⤷ Subscribe |
Glaxosmithkline | BECONASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018584-001 | Approved Prior to Jan 1, 1982 | 4,414,209 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription